Poland vs Spain: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Poland
89.0%
in 2025
Spain
89.0%
in 2025
Poland rank
72nd
Spain rank
72nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Poland
- Spain
How they compare
Poland currently reports 89.0% against 89.0% in Spain, a difference of 0.0%.
Across all 18 years both countries report, Spain has been ahead every year.
Poland ranks 72nd and Spain ranks 72nd of 194 countries.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Poland | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 14.9% | 27.8% | 12.9% | Spain |
| 2020s | 88.5% | 92.5% | 4.0% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Poland or Spain?
- Poland, at 89.0% against 89.0% in Spain as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Poland and Spain?
- 0.0%, with Poland ahead.
- How many years of comparable data are there for Poland and Spain?
- 18 years are reported by both, from 2008 to 2025.
- How do Poland and Spain rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Poland ranks 72nd and Spain ranks 72nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.